| 000 | 01884 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514032518.0 | ||
| 264 | 0 | _c20020819 | |
| 008 | 200208s 0 0 ger d | ||
| 022 | _a0300-5860 | ||
| 024 | 7 |
_a10.1007/s003920200016 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPeters, S | |
| 245 | 0 | 0 |
_a[Pilot study of the effectiveness of combination therapy with reduced dose alteplase and the glycoprotein IIb/IIIa antagonist tirofiban in acute myocardial infarct]. _h[electronic resource] |
| 260 |
_bZeitschrift fur Kardiologie _cMar 2002 |
||
| 300 |
_a233-7 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAngioplasty, Balloon, Coronary |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aCoronary Angiography |
| 650 | 0 | 4 |
_aCoronary Circulation _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdiagnostic imaging |
| 650 | 0 | 4 | _aOutcome and Process Assessment, Health Care |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
| 650 | 0 | 4 | _aStents |
| 650 | 0 | 4 | _aThrombolytic Therapy |
| 650 | 0 | 4 | _aTirofiban |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xadministration & dosage |
| 650 | 0 | 4 |
_aTyrosine _xadministration & dosage |
| 700 | 1 | _aTrümmel, M | |
| 700 | 1 | _aBrattström, A | |
| 700 | 1 | _aMeyners, W | |
| 773 | 0 |
_tZeitschrift fur Kardiologie _gvol. 91 _gno. 3 _gp. 233-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s003920200016 _zAvailable from publisher's website |
| 999 |
_c11900444 _d11900444 |
||